BioNTech SE is 16.9x more valuable than Maze Therapeutics, Inc. by market capitalization ($21.79 B vs $1.29 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | MAZE | BNTX |
|---|---|---|
| Market cap | $1.29 B | $21.79 B |
| US-listed rank | #2448 | #587 |
| Revenue (latest FY) | $167.50M | - |
| Net income (latest FY) | -$131.12M | - |
| Net margin | -78.3% | - |
| SEC filings | 165 | 548 |
BioNTech SE is 16.9x more valuable than Maze Therapeutics, Inc. by market capitalization ($21.79 B vs $1.29 B).
Full pages: Maze Therapeutics, Inc. and BioNTech SE, or browse the full rankings.